HOME › DRUGS › PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED)
ACTIVE SUBSTANCE / INN

PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED)

Brand name(s): Arepanrix
EMA LISTED
WITHDRAWN
Influenza, Human;Immunization;Disease Outbreaks
ACTIVE SUBSTANCE
Pandemic Influenza Vaccine (H1N1)V (Split Virion, Inactivated, Adjuvanted)
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Biologicals S.A.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ArepanrixGlaxoSmithKline Biologicals S.A.Withdrawn23/03/2010Influenza, Human;Immunization;Disease Outbreaks

FULL INTELLIGENCE ON PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →